EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact

Thomas P Monath

Viruses · 28.12.2023 · 16 (1) · 54

DOI: 10.3390/v16010054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 28.12.2023. Verfasst von Thomas P Monath. Beteiligte Einrichtung: Quigley BioPharma LLC, 114 Water Tower Plaza No. 1042, Leominster, MA 01453, USA. Hauptthemen laut MEDLINE: Encephalitis, Japanese, Encephalitis Virus, Japanese, Encephalitis, Viral, Chiroptera. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Japanese encephalitis virus is a mosquito-borne member of the Flaviviridae family. JEV is the leading cause of viral encephalitis in Asia and is characterized by encephalitis, high lethality, and neurological sequelae in survivors. The virus also causes severe disease in swine, which are an amplifying host in the transmission cycle, and in horses. US agricultural authorities have recently recognized the threat to the swine industry and initiated preparedness activities. Other mosquito-borne viruses exotic to the Western Hemisphere have been introduced and established in recent years, including West Nile, Zika, and chikungunya viruses, and JEV has recently invaded continental Australia for the first time. These events amply illustrate the potential threat of JEV to US health security. Susceptible indigenous mosquito vectors, birds, feral and domestic pigs, and possibly bats, constitute the receptive ecological ingredients for the spread of JEV in the US. Fortunately, unlike the other virus invaders mentioned above, an inactivated whole virus JE vaccine (IXIARO®) has been approved by the US Food and Drug Administration for human use in advance of a public health emergency, but there is no veterinary vaccine. This paper describes the risks and potential consequences of the introduction of JEV into the US, the need to integrate planning for such an event in public health policy, and the requirement for additional countermeasures, including antiviral drugs and an improved single dose vaccine that elicits durable immunity in both humans and livestock.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis, JapaneseEncephalitis Virus, JapaneseEncephalitis, ViralChiropteraCulicidaeVaccinesZika VirusZika Virus InfectionHumansUnited StatesAnimalsHorsesSwineAgriculture

Stichwörter der Autor:innen

FlaviviridaeFlavivirusJapanese encephalitisemerging diseasevaccineveterinary vaccinezoonosis

Substanzen

Vaccines

Autor:innen und Institutionen

  • Quigley BioPharma LLC, 114 Water Tower Plaza No. 1042, Leominster, MA 01453, USA.

Zitieren

APA

Monath, T. P. (2023). Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact. Viruses, 16(1), 54. https://doi.org/10.3390/v16010054

Vancouver

Monath TP. Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact. Viruses. 2023;16(1):54. doi:10.3390/v16010054

BibTeX
@article{Monath2023,
  author = {Monath, Thomas P},
  title = {Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact},
  journal = {Viruses},
  year = {2023},
  volume = {16},
  number = {1},
  pages = {54},
  doi = {10.3390/v16010054}
}
Kostenlos starten →